Stay updated on Pembrolizumab for Hepatocellular Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Hepatocellular Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Hepatocellular Carcinoma Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-05-01T05:43:11.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    The page has undergone significant content changes, including the removal of detailed eligibility criteria and study objectives for a clinical trial involving pembrolizumab in patients with HBV-related HCC, while a new version number has been added.
    Difference
    59%
    Check dated 2025-04-16T14:43:06.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.1%
    Check dated 2025-04-09T10:15:04.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1%
    Check dated 2025-02-24T22:31:27.000Z thumbnail image
  8. Check
    100 days ago
    Change Detected
    Summary
    The web page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    1%
    Check dated 2025-02-10T15:16:57.000Z thumbnail image
  9. Check
    107 days ago
    Change Detected
    Summary
    The website has been updated from version v2.14.1 to v2.14.2.
    Difference
    0.1%
    Check dated 2025-02-03T10:36:18.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Hepatocellular Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Hepatocellular Carcinoma Clinical Trial page.